Oakmont Advisory Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Oakmont Advisory Group's CL Position: Q2 2026 in Review
Oakmont Advisory Group increased its Colgate-Palmolive (CL) stake by 9.8% in Q2 2026, buying an estimated $29.9K and bringing the position to 3,844 shares worth $352K. The position accounts for 0.3% of the portfolio, ranked #93.
Oakmont Advisory Group first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,003 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Oakmont Advisory Group held 3,844 shares of Colgate-Palmolive worth $352K as of Q2 2026.
- Oakmont Advisory Group bought 342 Colgate-Palmolive shares in Q2 2026, an estimated $29.9K.
- Colgate-Palmolive made up 0.3% of Oakmont Advisory Group's portfolio in Q2 2026, its #93 holding.
- Oakmont Advisory Group first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
- 2,003 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Oakmont Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.